SEER
Seer, Inc.
A biotechnology company that helps scientists study the proteome—the full set of proteins in a body—using its Proteograph product suite, which relies on engineered nanoparticles that naturally gather proteins from blood samples. Founded in 2017 by researchers including Robert Langer, it grew out of nanoparticle work at Harvard's Brigham and Women's Hospital. The name "Seer" means one who sees, a nod to giving researchers a clearer view of proteins that were once hard to detect.
CUSIP: 81578P106HealthcareUS1 holder
Total Value
$9.01M
Total Shares
1.16M
Net Share Change
-1.01M
Activity
1 selling
Investor
Value
Shares
Weight
Change
